Nicholas Maestas
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nicholas Maestas
Earlier roles on record: CFO at Tempest Therapeutics, Inc. (TPST) until June 5, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed June 4, 2026 that Nicholas Maestas resigned as Chief Financial Officer, effective June 5, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed September 23, 2022 that Nicholas Maestas was appointed Secretary, effective September 30, 2022. The proxy statement of Tempest Therapeutics, Inc. reports total compensation of $622,095 for Nicholas Maestas in fiscal 2024, including a base salary of $365,547. Disclosed compensation is on record for 2 fiscal years.
“On May 29, 2026, Mr. Nicholas Maestas notified Tempest Therapeutics, Inc. (the “Company”) of his decision to resign from his position as Chief Financial Officer of the Company and from any and all other positions he holds with the Company, effective as of June 5, 2026.”
“The Board also appointed Nicholas Maestas, the Company's Vice President, Strategy and Finance, as the Company's Secretary, effective September 30, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Tempest Therapeutics, Inc. (TPST)
Proxy statement
Start not stated–2024-04-23
Last confirmed by a filing; no departure on record
-
Start not stated–2026-06-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Tempest Therapeutics, Inc. (TPST) | Chief Financial Officer | $365,547 | $622,095 |
| 2023 | Tempest Therapeutics, Inc. (TPST) | VP, Strategy and Finance | $351,488 | $1,319,038 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.